Latin American Leaders at WUF13 Push for New Housing Finance Models and ClimateResilient Urban Development Dow SP 500 Nasdaq Futures Dip as USIran Negotiations Create Uncertainty European Telecoms CEO Warns of US Satellite and AI Dominance Europe Doesnt Realize How Dangerous It Is Pakistan Deploys Paramilitary Force to Secure Strategic CopperGold Belt Micron Technology Achieves 1 Trillion Market Cap Milestone Amid AIDriven Memory Demand Ford Stock Surges 31 Since May Low as Institutional Investors Load Up on LongDated Call Options OSS Q1 2026 Earnings Earnings Beat Driven by Cost Discipline and Strong Demand in AIHPC NOAH Q3 2025 Earnings Strong EPS Performance Amidst Undisclosed Revenue Public Storage PSA Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response ALLT Q1 2026 Earnings EPS Surpasses Estimates by 3575 Despite Flat Stock Response DRDGOLD Q3 2014 Earnings NarrowerThanExpected Loss Amidst Challenging Gold Market SOJC Q1 2026 Earnings Southern Company Beats EPS Estimates Amid Solid Utility Performance Nuveen Municipal Credit Income Fund NZF Holds Slim Gains Near Resistance Level Gamehaus Holdings GMHS Slips 5 as Stock Approaches Key Support at 092 Zedge Inc ZDGE Faces Resistance as Stock Declines 233 Oragenics Inc OGEN Edges Higher as Biotech Volatility Persists Xcel Brands XELB Slips Over 6 as Shares Approach Critical Support Zone AI Security Debt Reduction A Practical Roadmap for Enterprises Permian Resources PR Q1 2026 Earnings Significant EPS Miss Amid Operational Headwinds Public Storage PSA Holds Steady Near 305 as Traders Eye Key Resistance Levels TLK Q4 2025 Earnings Significant EPS Miss Sends Shares Lower ASTS Q1 2026 Earnings PreRevenue Company Misses Deeply on EPS Yet Shares Rally on Operational Milestones CBRL Q1 2026 Earnings Significant EPS Beat Surprises Market AIM ImmunoTech Q1 2026 Earnings EPS Miss Widens as Clinical Pipeline Drives Higher Operating Costs DUOT Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Reaction BATL Q2 2023 Earnings EPS Slightly Beats Estimates Amidst Steep Stock Decline RenovoRx Q1 2026 Earnings EPS Miss as PreRevenue Biotech Continues Clinical Development